Portfolio of Genetic Testing Stocks

Here are 8 genetic testing stocks.

8 Genetic Testing Stocks

Stock Returns & Price Chart

Symbol

Recent Prices &
Annualized Return

Genomic HealthGHDX
Cancer GeneticsCGIX
Exact SciencesEXAS
Genetic Technologies LtdGENE
HTG Molecular DiagnosticsHTGM
InvitaeNVTA
NateraNTRA
VeracyteVCYT
Price data from Quandl as of most recent close.


8 Genetic Testing Stocks

Stock Returns & Price Chart

Symbol

Recent Dividends

Genomic HealthGHDX
Cancer GeneticsCGIX
Exact SciencesEXAS
Genetic Technologies LtdGENE
HTG Molecular DiagnosticsHTGM
InvitaeNVTA
NateraNTRA
VeracyteVCYT
Dividend chart data from Quandl as of today.


To inspect the performance of the Genetic Testing Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.

The 3 stocks included in the portfolio computations are: GHDX, EXAS and GENE. The current value of the portfolio assumes that $3,333.33 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. The 5 stocks excluded from the portfolio computations because of insufficient price data are: CGIX, HTGM, NVTA, NTRA and VCYT.

The current value of a $10,000 investment is $80,466. The percent return is 704.66%. The annualized return is 23.85%.



Return Summary for Genetic Testing Stocks
Start DateApr-30-2010
Start Investment$10,000.00
End DateJan-28-2020
Current Value of Investment$80,465.66
Total Return704.66%
Annualized Return23.85%
Min DateJul-30-2010
Min Price$8,231.62
Max DateJun-28-2019
Max Price$100,900.70
# Monthly Prices118
Number Returns6,903
Number Profitable Returns5,167
Percent Profitable Returns74.85%
Number Unprofitable Returns1,736
Percent Unprofitable Returns25.15%
Profitable to Unprofitable Returns Ratio2.98


NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.

Use Stock Symbol and Stock Portfolio Finder to find a stock in a buyupside.com portfolio.

Related Portfolios

Portfolio of Gene Editing (CRISPR) Stocks

Portfolio of Genomics Stocks

Portfolio of Stem Cell Stocks